TCL Archive Congressional Committee, SEC Probe ImClone’s Statements To Shareholders. January 25, 2002
TCL Archive Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”. February 15, 2002
TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012